chr12-6495103-C-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP6_ModerateBS1
The NM_014865.4(NCAPD2):āc.5C>Gā(p.Ala2Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000199 in 1,614,110 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/23 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_014865.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NCAPD2 | NM_014865.4 | c.5C>G | p.Ala2Gly | missense_variant | 2/32 | ENST00000315579.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NCAPD2 | ENST00000315579.10 | c.5C>G | p.Ala2Gly | missense_variant | 2/32 | 1 | NM_014865.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00106 AC: 161AN: 152200Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000302 AC: 76AN: 251412Hom.: 0 AF XY: 0.000243 AC XY: 33AN XY: 135876
GnomAD4 exome AF: 0.000111 AC: 162AN: 1461792Hom.: 0 Cov.: 30 AF XY: 0.0000963 AC XY: 70AN XY: 727196
GnomAD4 genome AF: 0.00105 AC: 160AN: 152318Hom.: 0 Cov.: 33 AF XY: 0.00106 AC XY: 79AN XY: 74480
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 10, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
NCAPD2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 15, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at